Document is current
Any future updates will be listed below
-
Authors
Stewart, C. Allison
Gay, Carl M.
Xi, Yuanxin
Sivajothi, Santhosh
Sivakamasundari, V.
Fujimoto, Junya
Bolisetty, Mohan
Hartsfield, Patrice M.
Balasubramaniyan, Veerakumar
Chalishazar, Milind D.
Moran, Cesar
Kalhor, Neda
Stewart, John
Tran, Hai
Swisher, Stephen G.
Roth, Jack A.
Zhang, Jianjun
de Groot, John
Glisson, Bonnie
Oliver, Trudy G. https://orcid.org/0000-0003-2082-2397
Heymach, John V.
Wistuba, Ignacio
Robson, Paul https://orcid.org/0000-0002-0191-3958
Wang, Jing
Byers, Lauren Averett https://orcid.org/0000-0002-0780-2677
- License Information
-
More Information
Article History
Received: 12 August 2019
Accepted: 12 December 2019
First Online: 17 February 2020
Competing interests
: L.A.B. serves on advisory committees for AstraZeneca, AbbVie, Genmab, BerGenBio, Pharma Mar SA, Sierra Oncology, Merck, Bristol-Myers Squibb, Genentech and Pfizer and has research support from AbbVie, AstraZeneca, Genmab, Sierra Oncology and Tolero Pharmaceuticals. J.V.H. serves on advisory committees for AstraZeneca, Boehringer Ingelheim, Exelixis, Genentech, GlaxoSmithKline, Guardant Health, Hengrui, Lilly, Novartis, Spectrum, EMD Serono and Synta, and has research support from AstraZeneca, Bayer, GlaxoSmithKline and Spectrum and royalties and licensing fees from Spectrum. Otherwise, there are no pertinent financial or non-financial conflicts of interest to report.
